Highlights
ASX: ACW       ACTINOGEN MEDICAL LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.008   0.00 (0.00%)  0.008 - 0.008  238,500

Overview

 
Avg Volume (4 weeks):2,697,560
4 Weeks Range:0.007 - 0.009
4 Weeks Price Volatility (%):
50.00%
52 Weeks Range:0.007 - 0.06
52 Weeks Price Volatility (%):
1.89%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Actinogen Medical Limited, formerly Actinogen Limited, is a clinical-stage biotechnology company. The Company focuses on the treatment of Alzheimer's disease and age-related neurodegenerative diseases. The Company is engaged in treating cognitive impairment in chronic neurodegenerative diseases through the inhibition of cortisol production. The Company's Xanamem is a drug under development for the treatment of Alzheimer's disease, which is designed to block the production of cortisol in the brain. Xanamem's mechanism of action is to block the activity of a specific enzyme in the brain, the 11B-HSD1 enzyme. It focuses on Xanamem in the clinical areas, including Diabetes-Cognitive dysfunction, Cognitive dysfunction in Parkinson's Disease, Post Traumatic Stress Disorder (PTSD), Cognitive dysfunction in schizophrenia and depression, and Cardiovascular disease-Post myocardial infarction. It focuses on Phase II XanADu efficacy and safety study with mild Alzheimer's disease patients.

  Be the first to like this.
 


 

585  637  672  9275 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GOR 1.305+0.005 
 GMG 13.83-0.06 
 AVH 0.605-0.01 
 CMW 1.30+0.025 
 SLR 1.02+0.03 
 ANW 0.003-0.003 
 BMG 0.007-0.005 
 TLS 3.65+0.01 
 PNV 2.24-0.04 
 BPT 2.57-0.03 
Partners & Brokers